|Bid||45.66 x 900|
|Ask||46.33 x 2200|
|Day's Range||45.59 - 46.38|
|52 Week Range||42.17 - 58.31|
|Beta (3Y Monthly)||1.60|
|PE Ratio (TTM)||4,595.00|
|Earnings Date||Aug 5, 2019 - Aug 9, 2019|
|Forward Dividend & Yield||1.91 (3.91%)|
|1y Target Est||53.00|
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Cardinal Health, Inc. New York, May 17, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Cardinal Health, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
It's always frustrating when a company is performing well and yet its share price has not followed. Adjusted earnings per share hit an all-time high in 2018 but, as of May 13, 2019, the stock was available for just $46.40. Since 2010, Cardinal's cash flow, earnings and dividends per share were up from 120% to 176%.
Cardinal Health Inc. has renewed its largest customer, CVS, but the medical supply side of the business continues to struggle.
Cardinal Health (CAH) Q3 results benefit from strong performance by Pharmaceutical segment and higher revenues. However, sluggishness in the Medical segment remains a concern.
Our call of the day, from Steve Eisman, a hedge-fund trader who made money in the financial crisis by betting against risky mortgage products engineered by some of the world’s biggest banks, says corporate bonds will be at the center of pain for the next U.S. recession.
Shares of Cardinal Health Inc. surged 2.6% in premarket trade Thursday, after the healthcare services and products company reported fiscal third-quarter earnings and revenue that rose above expectations and raised its full-year profit guidance. Net earnings for the quarter to March 31 rose to $296 million, or 99 cents a share, from $255 million, or 81 cents a share, in the same period a year ago. Excluding non-recurring items, adjusted EPS was $1.59, above the FactSet consensus of $1.43. Revenue rose 5% to $35.23 billion, above the FactSet consensus of $35.07 billion. Pharmaceutical revenue grew 6% to $31.4 billion, above the FactSet consensus of $31.1 billion, while medical revenue fell 1% to $3.9 billion to match expectations. For fiscal 2019, the company raised its adjusted EPS guidance range to $5.02 to $5.17 from $4.97 to $5.17; the FactSet consensus was $5.08. The stock has rallied 11.5% year to date, while the SPDR Health Care Select Sector ETF has edged up 3.0% and the S&P 500 has advanced 14.9%.
On a per-share basis, the Dublin, Ohio-based company said it had net income of 99 cents. Earnings, adjusted for amortization costs and restructuring costs, came to $1.59 per share. The results topped Wall ...
-- Revenue increased 5 percent to $35.2 billion -- GAAP(1) operating earnings decreased 21 percent to $432 million , and non-GAAP operating earnings decreased 15 percent to $667 million -- GAAP diluted ...
is expected to report quarterly earnings of $1.43 a share on sales of $35.1 billion before the market opens on Thursday, based on a FactSet survey of 16 analysts. Cardinal Health is currently trading at a price-to-forward-earnings ratio of 9.4 based on the 12-month estimates of 19 analysts surveyed by FactSet. Cardinal Health Inc. is one of the stocks Real Money's Paul Price is watching closely.
DUBLIN, Ohio , May 8, 2019 /PRNewswire/ -- Clinicians report spending more than twice the amount of time they would like to on supply chain-related tasks, and as a result have less time with patients and ...
Cardinal Health (CAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Cardinal Health Inc NYSE:CAHView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for CAH with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.98 billion over the last one-month into ETFs that hold CAH are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. CAH credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.